News On Japan

Shionogi Covid pill Xocova fails to win Japan panel backing

Jul 21 (theedgemarkets.com) - Shionogi's experimental Covid-19 treatment Xocova failed to win the backing of health experts in Japan who said there wasn’t enough data to show the medicine’s efficacy.

The panel members didn’t recommend that Japan’s health ministry authorise emergency use of the therapy as there was a need to continue discussion on it, Hiroshi Kiyota, chairman of the expert committee said in a briefing Wednesday. The health ministry relies on the panel’s decision to give the approval.

Shionogi plummeted as much as 10% in Tokyo trading, the biggest intraday drop since June 23, while shares of Shionogi’s South Korean partner, Il Dong Pharmaceutical Co, fell as much as 30% in Seoul.

Japan so far has two pills to fight coronavirus and Shionogi’s therapy was seeking to be the third option. Approval for Shionogi’s medicine was keenly watched as it is easier to take than the two currently available drugs from US drugmakers. A course of Shionogi treatment consists of seven pills over five days — significantly fewer than Pfizer Inc’s Paxlovid and Merck & Co’s Lagevrio, which require between 30 pills and 40 pills over the same time period.

Source: ANNnewsCH

News On Japan
POPULAR NEWS

Bear sightings across Japan have already climbed to nearly twice the level recorded during the same period last year, prompting entry bans in mountain areas behind Kyoto’s Ninna-ji Temple and the cancellation of hiking events in Kansai, while new research suggests that the key to reducing encounters may lie in understanding what bears eat in each region.

Copper roofing panels were stolen from several shrines in Hamamatsu, Shizuoka Prefecture, including a city-designated cultural property, in the latest case amid a nationwide surge in copper thefts targeting shrines and temples across Japan, where soaring metal prices have fueled crimes that leave historic religious buildings damaged, exposed to the elements, and facing repair costs of millions of yen.

Flames broke out on the morning of May 20th on Miyajima Island in Hiroshima Prefecture, home to one of Japan's World Heritage sites, destroying Reikado Hall near the summit of Mount Misen.

Uncertainty surrounding the situation in the Middle East is beginning to affect daily life in Japan, as concerns over crude oil supplies spread to restaurants, cleaning services and even household garbage disposal systems across the Kansai region.

A 25-year-old woman arrested as a suspected ringleader in a robbery-murder case in Tochigi Prefecture once posted cheerful dance videos on social media and was remembered by those who knew her as an energetic and outgoing young woman.

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

A safety alert is expected to be issued as early as May 21st over Tavneos, a drug used to treat vasculitis, after 20 patients who took the medication died from serious liver dysfunction, according to people familiar with the matter.

As aging underground infrastructure becomes an increasing concern across Japan, the city of Yokkaichi in Mie Prefecture has developed a digital underground map designed to improve the management of sewer, water, gas, and electrical systems.

Japan's Health, Labour and Welfare Ministry said on May 18th it had instructed Kissei Pharmaceutical to report the facts surrounding the deaths of 20 patients who had taken a treatment drug for vasculitis.

A mysterious object floating softly through the air has captured widespread attention online, with researchers at Nagoya University developing an ultra-lightweight material that appears to behave like a real-life “flying carpet.”

Japan has approved the application of public health insurance to a regenerative medicine product using iPS cells to treat Parkinson’s disease, marking the world’s first practical use of iPS cell-based regenerative medicine.

A crack was found in the cover surrounding the high-pressure turbine at Kansai Electric Power’s Mihama Nuclear Power Plant No. 3 reactor in Mihama, Fukui Prefecture, following a steam leak that occurred last week, the utility said.

Japan has approved the domestic manufacture and sale of an MMR vaccine that protects against measles, mumps, and rubella with a single injection, paving the way for its use in children aged one and older.

A steam leak was detected early on May 8th at the Mihama Nuclear Power Plant's Unit 3 in Fukui Prefecture, prompting Kansai Electric Power to manually shut down the reactor.